These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2046194)

  • 21. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
    Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S
    J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of lymph node dissection in renal cell carcinoma.
    Delacroix SE; Chapin BF; Wood CG
    Urol Clin North Am; 2011 Nov; 38(4):419-28, vi. PubMed ID: 22045173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding indications for conservative renal surgery in renal cell carcinoma.
    Thrasher JB; Robertson JE; Paulson DF
    Urology; 1994 Feb; 43(2):160-8. PubMed ID: 8116109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lymphadenectomy in renal cell carcinoma.
    Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
    Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
    Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
    J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controversies in surgical therapy of renal cell carcinoma].
    Schröder A; Lampel A; Eggersmann C; Thüroff JW
    Urologe A; 1997 Sep; 36(5):W460-6. PubMed ID: 9424788
    [No Abstract]   [Full Text] [Related]  

  • 40. A generation of laparoscopic nephrectomy: stage-specific surgical and oncologic outcomes for laparoscopic nephrectomy in a single center.
    Laird A; Stewart GD; Zhong J; Ang WJ; Cutress ML; Riddick AC; McNeill SA; Tolley DA
    J Endourol; 2013 Aug; 27(8):1008-14. PubMed ID: 23634886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.